Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis
Vladislav Volarević(University of Kragujevac), Miodrag L. Lukić(University of Kragujevac), Nebojša Arsenijević(University of Kragujevac), Ahmed A. Al‐Qahtani(United Arab Emirates University), Sladjana Pajović(University of Kragujevac)
Cited by 195
Related Papers
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
|Cells|2019|774
IL-1 family nomenclature
|Nature Immunology|2010|341
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
|International Journal of Cancer|2013|326
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304